Search
for
Sort by
Research 451–480 of 1000+
- Successful treatment of coexisting alopecia areata and hidradenitis suppurativa with upadacitinib
- Hair loss disorders (alopecias)
- Treatment Challenges in Alopecia Areata: Insights From a Case of Baricitinib Therapy Failure
- Real-Life Effectiveness and Tolerance of Baricitinib for the Treatment of Severe Alopecia Areata with 1-Year Follow-Up Data
- 43046 Outcomes of Down-Titration in Patients with Severe Scalp Alopecia Areata Treated with Baricitinib 4 Mg: Week 104 Data from BRAVE-AA2
- ISID1108 - Comparison of ruxolitinib and a collagen-targeted PTH-based hair cycle stimulant on hair follicle counts and hair growth in the C3H/HeJ engrafted mouse model of alopecia areata.
- A Promising Efficacy of Tofacitinib in an Adult Patient with Alopecia Areata
- Tofacitinib: A Promising Treatment for Adolescent Alopecia Areata
- Baricitinib for alopecia areata
- 32237 Clinician and patient evaluation of improvement for eyebrow and eyelashes hair loss during baricitinib phase 3 trials BRAVE-AA1 and BRAVE-AA2
- PSS20 MEDIATION MODELING AND MEASUREMENT CHARACTERISTICS OF THE ITCH SEVERITY SCORE FROM A PHASE 2B TRIAL OF ORAL CP-690-550 IN PATIENTS WITH MODERATE TO-SEVERE PLAQUE PSORIASIS
- Upadacitinib for management of recalcitrant alopecia areata: A retrospective case series
- Clinical Outcomes for Uptitration of Baricitinib Therapy in Patients With Severe Alopecia Areata
- Tofacitinib for the treatment of severe alopecia areata and variants: A retrospective cohort study of 90 patients
- Autophagy Stimulation Improves Erythroid Proliferative Capacity in Models of SF3B1 Mutant MDS
- Les Rencontres d’Experts du Psoriasis : des recommandations pour la pratique quotidienne
- Successful treatment of concomitant alopecia universalis and Crohn’s disease with upadacitinib: A case report
- New Treatment Strategies in Management of Alopecia Areata: Review Article
- Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis
- The PDGF/PDGFR pathway as a drug target
- Anti-EGFR mechanism of action: antitumor effect and underlying cause of adverse events.
- Ritlecitinib: First Approval
- A Case of Cicatricial Alopecia Associated with Erlotinib
- The role of oclacitinib in the management of ischaemic dermatopathy in four dogs
- Treatments options for alopecia
- Reversal of Alopecia Universalis by Tofacitinib: A Case Report
- Nilontinib induced keratosis pilaris atrophicans
- Single‐cell transcriptomics reveals a senescence‐associated IL ‐6/ CCR6 axis driving radiodermatitis
- Ruxolitinib found to cause eyelash growth: a case report
- Dasatinib-Induced Leukotrichia in a Patient With Chronic Myelogenous Leukemia